Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2013 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Vanguard Dividend Appreciation ETF | 24 | Q3 2023 | 13.4% |
iShares S&P 500 Value ETF | 24 | Q3 2023 | 10.4% |
Microsoft Corp | 24 | Q3 2023 | 2.7% |
Oracle Corp | 24 | Q3 2023 | 1.7% |
Vanguard S&P 500 ETF | 24 | Q3 2023 | 1.9% |
Novo Nordisk A/S Spons Adr | 24 | Q3 2023 | 1.4% |
Vanguard S&P 500 Value ETF | 24 | Q3 2023 | 3.9% |
Johnson & Johnson | 24 | Q3 2023 | 1.2% |
Nike Inc Cl B | 24 | Q3 2023 | 1.2% |
SPDR S&P 500 ETF | 24 | Q3 2023 | 1.2% |
View Arlington Partners LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-16 |
13F-HR | 2024-01-24 |
13F-HR | 2023-10-24 |
13F-HR | 2023-07-26 |
13F-HR | 2023-04-26 |
13F-HR/A | 2023-01-24 |
13F-HR | 2023-01-19 |
13F-HR | 2022-10-28 |
13F-HR | 2022-07-25 |
13F-HR | 2022-04-14 |
View Arlington Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.